Results 121 to 130 of about 98,806 (295)

Efficacy and safety of vutrisiran in transthyretin amyloid cardiomyopathy across the age spectrum: The HELIOS‐B trial

European Journal of Heart Failure, EarlyView.
Summary of the HELIOS‐B trial design. Right: Forest (top) and spline (bottom) plots demonstrating the effect of vutrisiran versus placebo on clinical outcomes across age groups in HELIOS‐B. Age‐stratified outcomes with vutrisiran in transthyretin amyloid cardiomyopathy.
Awais Sheikh, Zi Michael Miao, Brian Claggett, Pablo Garcia‐Pavia, Francesco Cappelli, Emre Aldinc, Julian Gillmore, Scott D. Solomon, Marianna Fontana   +8 more
wiley   +1 more source

Improving genetic testing pathways for transthyretin amyloidosis in France: challenges and strategies

Orphanet Journal of Rare Diseases
Transthyretin amyloidosis (ATTR) is a severe and rare disease characterized by the progressive deposition of misfolded transthyretin proteins, causing irreversible organ damage.
Bérénice Hebrard, Marie-Lise Babonneau, Philippe Charron, Emilie Consolino, Benjamin Dauriat, Delphine Dupin-Deguine, Dominique Fargeaud, Agnès Farrugia, Anna-Gaëlle Giguet-Valard, Damien Guijarro, Jocelyn Inamo, Julien Jeanneteau, Jean-Michaël Mazzella, Claire-Cécile Michon, Gilles Millat, Frédéric Mouquet, Silvia Oghina, Yann Pereon, Vianney Poinsignon, Julie Pompougnac, Julie Proukhnitzky, Elise Schaefer, Franck Sturtz, Mathilde Trosdorf, Anne Auguste, Giorgia Canali, Alexandre Combes, Benoît Funalot, Thibaud Damy   +28 more
doaj   +1 more source

Positron Emission Tomography Can Support the Diagnosis of Dialysis-Related Amyloidosis [PDF]

, 2019
Giulia Santagati, Emanuela Cataldo, Valeria Columbano, Antoine Chatrenet, Daniele Penna, Ettore Pelosi, Mammar Hachemi, Lurlinys Gendrot, Louise Møldrup Nielsen, Francesco Cinquantini, Patrick Saulnier, Vincenzo Arena, C. Boursot, Giorgina Barbara Piccoli   +13 more
openalex   +1 more source

An Atypical Presentation of Insulin Amyloidosis: An Uncommon but Important Complication of Insulin Therapy

, 2017
Catherine Sullivan, Reyhan Gedik, Shirin Haddady   +2 more
openalex   +1 more source

Pathology of Pulmonary Vein Isolation in a Patient With Transthyretin-Related Amyloidosis

, 2021
Hiyo Obikane, Suguru Migita, Kenichi Yoshida, Sayaka Shimodai‐Yamada, Yasuo Okumura, Hiroyuki Hao   +5 more
openalex   +2 more sources

Molecular imprinting for neurology: Materials, applications, and limitations

Ibrain, EarlyView.
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma, Yingqi Ma, Claudia Marino, Alessandro Poma   +3 more
wiley   +1 more source

Renal Response Criteria for Clinical Trials in Amyloid Light Chain Amyloidosis [PDF]

Nelson Leung, Raymond L. Comenzo, Julian D. Gillmore, Andrea Havasi, Efstathios Kastritis, Spencer Guthrie, James Signorovitch, Dena Heath, Isabelle Lousada, Yolanda Barbáchano, Krishna Prasad, Kimberly A. Smith   +11 more
openalex   +1 more source

Case of lifetime diagnosis of isolated primary amyloidosis of the heart

, 2022
И. В. Демко, L. I. Pelinovskaya, А. Yu. Kraposhina, V. E. Selin, A. E. Ryazanov, Y. I. Verigo, V. A. Mosina   +6 more
openalex   +1 more source

Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans

Blood Cancer Journal, 2022
Andrew Staron, Luke Zheng, Gheorghe Doros, Vaishali Sanchorawala   +3 more
doaj   +1 more source

Effect of plasmapheresis on systemic amyloidosis

, 1988
Yoshihiro Takamitsu, Takafumi Yura, Shigekazu Yuasa, Shigehiro Miki, Megumu Fukunaga, Kanji Yoshida, Tohru Sumikura, Tetsuro Ohnishi, Norihiro Takahashi, Hirohíde Matsuo   +9 more
openalex   +2 more sources